Polymeric carrier

Details for Australian Patent Application No. 2009246321 (hide)

Owner University of Washington Phaserx, Inc.

Inventors Paschal, Amber; Hoffman, Allan S.; Gall, Anna; Prieve, Mary; De, Priyadarsi; Convertine, Anthony J.; Overell, Robert; Stayton, Patrick S.; Diab, Charbel; Johnson, Paul; Duvall, Craig L.; Benoit, Danielle

Agent Spruson & Ferguson

Pub. Number AU-A-2009246321

PCT Pub. Number WO2009/140421

Priority 61/052,914 13.05.08 US; 61/112,054 06.11.08 US; 61/052,908 13.05.08 US; 61/171,358 21.04.09 US; 61/140,779 24.12.08 US; 61/091,294 22.08.08 US

Filing date 13 May 2009

Wipo publication date 19 November 2009

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

23 December 2010 PCT application entered the National Phase

  PCT publication WO2009/140421 Priority application(s): WO2009/140421

20 January 2011 Alteration of Name

  The name of the applicant has been altered to University of Washington; PhaseRx, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009246322-Ember-resistant and flame-resistant roof ventilation system

2009246316-Treatment for epilepsy